Ditchcarbon
  • Customers
  1. Organizations
  2. Formycon AG
Public Profile
Pharmaceutical Preparation Manufacturing
DE
updated 7 days ago

Formycon AG

Company website

Formycon AG, a leading biopharmaceutical company headquartered in Germany, is renowned for its expertise in the development of biosimilars. Founded in 2002, the company has established a strong presence in Europe and beyond, focusing on innovative therapies that enhance patient care. With a commitment to quality and efficacy, Formycon AG offers a range of biosimilar products that stand out for their rigorous development processes and regulatory compliance. The company has achieved significant milestones, including successful partnerships and product launches that underscore its position in the competitive biopharmaceutical landscape. Recognised for its scientific excellence, Formycon AG continues to drive advancements in the industry, making substantial contributions to the accessibility of biologic treatments for patients worldwide.

DitchCarbon Score

How does Formycon AG's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

22

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

27

Industry Benchmark

Formycon AG's score of 22 is lower than 78% of the industry. This can give you a sense of how well the company is doing compared to its peers.

22%

Let us know if this data was useful to you

Formycon AG's reported carbon emissions

Formycon AG, headquartered in Germany, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges from the company. As of now, Formycon AG does not inherit emissions data from any parent or related organizations, meaning all information is self-reported and reflects their independent status in terms of climate commitments. In the context of the biopharmaceutical industry, companies are increasingly focusing on sustainability and carbon neutrality. While Formycon AG has not yet established specific targets or initiatives, the industry trend suggests a growing emphasis on reducing carbon footprints and enhancing environmental responsibility. Overall, without specific emissions data or reduction commitments, Formycon AG's current climate strategy remains unclear, but the company is positioned within an industry that is progressively prioritising climate action.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Formycon AG's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Formycon AG is in DE, which has a medium grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Formycon AG is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Samsungbioepis Co,.Ltd

KR
•
Research and development services (73)
Updated about 14 hours ago

Novartis

CH
•
Pharmaceutical Preparation Manufacturing
Updated 3 days ago

Celltrion

KR
•
Pharmaceutical Preparation Manufacturing
Updated 9 days ago

Sandoz International GmbH

DE
•
Pharmaceutical Preparation Manufacturing
Updated 29 days ago

Alvotech

LU
•
Pharmaceutical Preparation Manufacturing
Updated 18 days ago

Fresenius

DE
•
Medical, precision and optical instruments, watches and clocks (33)
Updated 4 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v250915.3
enquiries@ditchcarbon.com+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
ProductPortalDataDocumentationIntegrationsChangelogPricing
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesMethodologyBlogFAQOrganizationsIndustriesSBTI APITrust Centre
AboutTeamCareersLicense AgreementPrivacy